NUDT1 and neoplasm: Considering the function of MTH1 and its high expression in tumor cells, together with the role of 8-oxoG in ROS-mediated tumor therapy, it may seem highly likely that the selectivity and efficiency of tumor therapy can be improved through combined administering of ROS-inducing agents with MTH1 inhibitors.